In breast cancer cells showing robust expression of AGR2 (i.e. MCF7 and MDA-MB-453), β-DG subunit was clearly up-regulated, whereas it was unchanged in cells expressing little or no AGR2 (i.e. MDA-MB-231) (Figure 1(A)). This evidence concerns the gene AGR2 and breast cancer.